{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T17:14:12Z","timestamp":1770743652934,"version":"3.49.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1245\/s10434-025-16971-0","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T19:15:07Z","timestamp":1738955707000},"page":"5283-5291","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["An Evaluation of Sentinel Lymph Node Biopsy Guideline Adherence in Melanoma"],"prefix":"10.1245","volume":"32","author":[{"given":"Amelia Stapleton","family":"Van Doren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hemali","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashar","family":"Ata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindy","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"key":"16971_CR1","unstructured":"Surveillance Research Program, National Cancer Institute. Surveillance, Epidemiology, and End Results Program (SEER) Cancer Stat Facts: Melanoma of the Skin. SEER*Explorer. 27 June 2024. Available at: https:\/\/seer.cancer.gov\/statfacts\/html\/melan.html. Accessed 31 Aug 2024."},{"issue":"5\u20136","key":"16971_CR2","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s10585-018-9898-6","volume":"35","author":"MB Faries","year":"2018","unstructured":"Faries MB, Han D, Reintgen M, Kerivan L, Reintgen D, Carac\u00f2 C. Lymph node metastasis in melanoma: a debate on the significance of nodal metastases, conditional survival analysis and clinical trials. Clin Exp Metastasis. 2018;35(5\u20136):431\u201342. https:\/\/doi.org\/10.1007\/s10585-018-9898-6.","journal-title":"Clin Exp Metastasis."},{"issue":"3","key":"16971_CR3","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.annonc.2020.11.015","volume":"32","author":"MA El Sharouni","year":"2021","unstructured":"El Sharouni MA, Stodell MD, Ahmed T, et al. Sentinel node biopsy in patients with melanoma improves the accuracy of staging when added to clinicopathological features of the primary tumor. Ann Oncol. 2021;32(3):375\u201383. https:\/\/doi.org\/10.1016\/j.annonc.2020.11.015.","journal-title":"Ann Oncol."},{"issue":"9","key":"16971_CR4","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1001\/jamasurg.2022.2055","volume":"157","author":"Multicenter Selective Lymphadenectomy Trials Study Group","year":"2022","unstructured":"Multicenter Selective Lymphadenectomy Trials Study Group. Therapeutic value of sentinel lymph node biopsy in patients with melanoma: a randomized clinical trial. JAMA Surg. 2022;157(9):835\u201342. https:\/\/doi.org\/10.1001\/jamasurg.2022.2055.","journal-title":"JAMA Surg."},{"key":"16971_CR5","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) Melanoma: Cutaneous Version 2.2024. Available at: NCCN.org."},{"issue":"4","key":"16971_CR6","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1200\/JCO.2017.75.7724","volume":"36","author":"SL Wong","year":"2018","unstructured":"Wong SL, Faries MB, Kennedy EB, et al. Sentinel lymph node biopsy and management of regional lymph nodes in melanoma: American society of clinical oncology and society of surgical oncology clinical practice guideline update. J Clin Oncol. 2018;36(4):399\u2013413. https:\/\/doi.org\/10.1200\/JCO.2017.75.7724.","journal-title":"J Clin Oncol."},{"issue":"3","key":"16971_CR7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/00008390-200106000-00013","volume":"11","author":"MG Statius Muller","year":"2001","unstructured":"Statius Muller MG, van Leeuwen PA, van Diest PJ, Vuylsteke RJ, Pijpers R, Meijer S. No indication for performing sentinel node biopsy in melanoma patients with a Breslow thickness of less than 0.9 mm. Melanoma Res. 2001;11(3):303\u20137. https:\/\/doi.org\/10.1097\/00008390-200106000-00013.","journal-title":"Melanoma Res."},{"issue":"1","key":"16971_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jaad.2005.09.029","volume":"54","author":"TM Johnson","year":"2006","unstructured":"Johnson TM, Sondak VK, Bichakjian CK, Sabel MS. The role of sentinel lymph node biopsy for melanoma: evidence assessment. J Am Acad Dermatol. 2006;54(1):19\u201327. https:\/\/doi.org\/10.1016\/j.jaad.2005.09.029.","journal-title":"J Am Acad Dermatol."},{"issue":"4","key":"16971_CR9","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.jaad.2022.11.033","volume":"88","author":"CE Sharon","year":"2023","unstructured":"Sharon CE, Straker RJ 3rd, Gimotty PA, et al. Sentinel lymph node biopsy status improves adjuvant therapy decision-making in patients with clinical stage IIB\/C melanoma: a population-based analysis. J Am Acad Dermatol. 2023;88(4):802\u20137. https:\/\/doi.org\/10.1016\/j.jaad.2022.11.033.","journal-title":"J Am Acad Dermatol."},{"issue":"11","key":"16971_CR10","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.3390\/medicina58111589","volume":"58","author":"DE Br\u0103ni\u015fteanu","year":"2022","unstructured":"Br\u0103ni\u015fteanu DE, Cozmin M, Porumb-Andrese E, et al. Sentinel lymph node biopsy in cutaneous melanoma, a clinical point of view. Medicina (Kaunas). 2022;58(11):1589. https:\/\/doi.org\/10.3390\/medicina58111589.","journal-title":"Medicina (Kaunas)."},{"issue":"12","key":"16971_CR11","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1002\/1097-0142(20010615)91:12<2401::AID-CNCR1274>3.0.CO;2-I","volume":"91","author":"MG Statius Muller","year":"2001","unstructured":"Statius Muller MG, van Leeuwen PA, de Lange-De Klerk ES, et al. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma. Cancer. 2001;91(12):2401\u20138.","journal-title":"Cancer."},{"issue":"4","key":"16971_CR12","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s10434-000-0262-z","volume":"7","author":"I Bedrosian","year":"2000","unstructured":"Bedrosian I, Faries MB, Guerry D 4th, et al. Incidence of sentinel node metastasis in patients with thin primary melanoma (< or = 1 mm) with vertical growth phase. Ann Surg Oncol. 2000;7(4):262\u20137. https:\/\/doi.org\/10.1007\/s10434-000-0262-z.","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"16971_CR13","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1245\/ASO.2005.04.027","volume":"12","author":"SB Kesmodel","year":"2005","unstructured":"Kesmodel SB, Karakousis GC, Botbyl JD, et al. Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas. Ann Surg Oncol. 2005;12(6):449\u201358. https:\/\/doi.org\/10.1245\/ASO.2005.04.027.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"16971_CR14","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1046\/j.1365-2133.2003.05502.x","volume":"149","author":"J Ol\u00e1h","year":"2003","unstructured":"Ol\u00e1h J, Gyulai R, Korom I, Varga E, Dobozy A. Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas. Br J Dermatol. 2003;149(3):662\u20133. https:\/\/doi.org\/10.1046\/j.1365-2133.2003.05502.x.","journal-title":"Br J Dermatol."},{"issue":"7","key":"16971_CR15","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa1310460","volume":"370","author":"DL Morton","year":"2014","unstructured":"Morton DL, Thompson JF, Cochran AJ, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370(7):599\u2013609. https:\/\/doi.org\/10.1056\/NEJMoa1310460.","journal-title":"N Engl J Med."},{"issue":"8","key":"16971_CR16","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/jso.21581","volume":"101","author":"SP Bagaria","year":"2010","unstructured":"Bagaria SP, Faries MB, Morton DL. Sentinel node biopsy in melanoma: technical considerations of the procedure as performed at the John Wayne Cancer Institute. J Surg Oncol. 2010;101(8):669\u201376. https:\/\/doi.org\/10.1002\/jso.21581.","journal-title":"J Surg Oncol."},{"issue":"1","key":"16971_CR17","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/jdv.19456","volume":"38","author":"J Huynh","year":"2024","unstructured":"Huynh J, Leiter U, Garbe C, et al. Sentinel lymph node biopsy for lentigo maligna melanoma under local anaesthesia. J Eur Acad Dermatol Venereol. 2024;38(1):84\u201392. https:\/\/doi.org\/10.1111\/jdv.19456.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"2","key":"16971_CR18","first-page":"315","volume":"26","author":"P Covarelli","year":"2012","unstructured":"Covarelli P, Badolato M, Tomassini GM, et al. Sentinel lymph node biopsy under local anaesthesia versus general anaesthesia: reliability and cost-effectiveness analysis in 153 patients with malignant melanoma. In Vivo. 2012;26(2):315\u20138.","journal-title":"In Vivo."},{"key":"16971_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.bjps.2023.09.040","volume":"87","author":"B Lanier","year":"2023","unstructured":"Lanier B, Khoshab N, Arora JS. Tumescent anesthesia use for cutaneous malignancies does not impact sentinel node identification but decreases estimated blood loss. J Plast Reconstr Aesthet Surg. 2023;87:131\u20134. https:\/\/doi.org\/10.1016\/j.bjps.2023.09.040.","journal-title":"J Plast Reconstr Aesthet Surg."},{"issue":"6","key":"16971_CR20","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1245\/aso.2003.10.001","volume":"10","author":"WR Wrightson","year":"2003","unstructured":"Wrightson WR, Wong SL, Edwards MJ, et al. Complications associated with sentinel lymph node biopsy for melanoma. Ann Surg Oncol. 2003;10(6):676\u201380. https:\/\/doi.org\/10.1245\/aso.2003.10.001.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"16971_CR21","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/01.sla.0000181092.50141.fa","volume":"242","author":"DL Morton","year":"2005","unstructured":"Morton DL, Cochran AJ, Thompson JF, et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg. 2005;242(3):302\u201313. https:\/\/doi.org\/10.1097\/01.sla.0000181092.50141.fa.","journal-title":"Ann Surg."},{"issue":"4","key":"16971_CR22","doi-asserted-by":"publisher","first-page":"419","DOI":"10.31486\/toj.20.0162","volume":"21","author":"A Sajan","year":"2021","unstructured":"Sajan A, Griepp DW, Hakmi H, et al. Isosulfan blue and anaphylaxis. Ochsner J. 2021;21(4):419\u201324. https:\/\/doi.org\/10.31486\/toj.20.0162.","journal-title":"Ochsner J."},{"issue":"6","key":"16971_CR23","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3322\/caac.21409","volume":"67","author":"JE Gershenwald","year":"2017","unstructured":"Gershenwald JE, Scolyer RA, Hess KR, et al. Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer Eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(6):472\u201392. https:\/\/doi.org\/10.3322\/caac.21409.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"16971_CR24","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.jamcollsurg.2018.12.030","volume":"228","author":"ME Egger","year":"2019","unstructured":"Egger ME, Stevenson M, Bhutiani N, et al. Should sentinel lymph node biopsy be performed for all T1b melanomas in the new 8th edition American Joint Committee on Cancer Staging System? J Am Coll Surg. 2019;228(4):466\u201372. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2018.12.030.","journal-title":"J Am Coll Surg."},{"issue":"1","key":"16971_CR25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jaad.2022.09.040","volume":"88","author":"AB Shannon","year":"2023","unstructured":"Shannon AB, Sharon CE, Straker RJ 3rd, et al. Sentinel lymph node biopsy in patients with T1a cutaneous malignant melanoma: a multicenter cohort study. J Am Acad Dermatol. 2023;88(1):52\u20139. https:\/\/doi.org\/10.1016\/j.jaad.2022.09.040.","journal-title":"J Am Acad Dermatol."},{"issue":"2","key":"16971_CR26","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.jaad.2018.08.051","volume":"80","author":"RRZ Conic","year":"2019","unstructured":"Conic RRZ, Ko J, Damiani G, et al. Predictors of sentinel lymph node positivity in thin melanoma using the National Cancer Database. J Am Acad Dermatol. 2019;80(2):441\u20137. https:\/\/doi.org\/10.1016\/j.jaad.2018.08.051.","journal-title":"J Am Acad Dermatol."},{"issue":"30","key":"16971_CR27","doi-asserted-by":"publisher","first-page":"4794","DOI":"10.1200\/JCO.23.01136","volume":"41","author":"R Seth","year":"2023","unstructured":"Seth R, Agarwala SS, Messersmith H, et al. Systemic therapy for melanoma: ASCO guideline update. J Clin Oncol. 2023;41(30):4794\u2013820. https:\/\/doi.org\/10.1200\/JCO.23.01136.","journal-title":"J Clin Oncol."},{"key":"16971_CR28","unstructured":"Edge SB, American Cancer Society American Joint Committee on Cancer. AJCC Cancer Staging Handbook: From the AJCC Cancer Staging Manual. 8th Ed. Springer; 2017."},{"issue":"5","key":"16971_CR29","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.jaad.2017.11.041","volume":"78","author":"L Wheless","year":"2018","unstructured":"Wheless L, Isom CA, Hooks MA, Kauffmann RM. Mitotic rate is associated with positive lymph nodes in patients with thin melanomas. J Am Acad Dermatol. 2018;78(5):935\u201341. https:\/\/doi.org\/10.1016\/j.jaad.2017.11.041.","journal-title":"J Am Acad Dermatol."},{"key":"16971_CR30","unstructured":"Michaelson J, Laboratory for Quantitative Medicine. Melanoma Nodal Status Calculator. Melanoma nodal status calculator. 2007. Available at: http:\/\/www.lifemath.net\/cancer\/melanoma\/nodal\/index.php. Accessed 1 Sep 2024."},{"key":"16971_CR31","unstructured":"Memorial Sloan Kettering Cancer Center. Melanoma Nonogram: Risk of sentinel lymph node metastasis. 2005. Available at: https:\/\/www.mskcc.org\/nomograms\/melanoma\/sentinel_lymph_node_metastasis. Accessed 1 Sep 2024."},{"key":"16971_CR32","unstructured":"Melanoma Institute Australia. (2025). Sentinel node metastasis risk. Melanoma risk assessment tool. https:\/\/www.melanomarisk.org.au\/SNLForm"},{"issue":"12","key":"16971_CR33","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1111\/dsu.12351","volume":"39","author":"SR Freeman","year":"2013","unstructured":"Freeman SR, Gibbs BB, Brodland DG, Zitelli JA. Prognostic value of sentinel lymph node biopsy compared with that of Breslow thickness: implications for informed consent in patients with invasive melanoma. Dermatol Surg. 2013;39(12):1800\u201312. https:\/\/doi.org\/10.1111\/dsu.12351.","journal-title":"Dermatol Surg."},{"issue":"5","key":"16971_CR34","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.jaad.2018.01.030","volume":"78","author":"E Stiegel","year":"2018","unstructured":"Stiegel E, Xiong D, Ya J, et al. Prognostic value of sentinel lymph node biopsy according to Breslow thickness for cutaneous melanoma. J Am Acad Dermatol. 2018;78(5):942\u20138. https:\/\/doi.org\/10.1016\/j.jaad.2018.01.030.","journal-title":"J Am Acad Dermatol."},{"issue":"4","key":"16971_CR35","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.jaad.2018.11.026","volume":"80","author":"M Bigby","year":"2019","unstructured":"Bigby M, Zagarella S, Sladden M, Popescu CM. Time to reconsider the role of sentinel lymph node biopsy in melanoma. J Am Acad Dermatol. 2019;80(4):1168\u201371. https:\/\/doi.org\/10.1016\/j.jaad.2018.11.026.","journal-title":"J Am Acad Dermatol."},{"key":"16971_CR36","doi-asserted-by":"publisher","unstructured":"Multicenter Selective Lymphadenectomy Trials Study Group, Crystal JS, Thompson JF, et al. Therapeutic value of sentinel lymph node biopsy in patients with melanoma: a randomized clinical trial [published correction appears in JAMA Surg. 2022 Sep;157(9):859. https:\/\/doi.org\/10.1001\/jamasurg.2022.4558].\u00a0JAMA Surg. 2022;157(9):835-842. https:\/\/doi.org\/10.1001\/jamasurg.2022.2055","DOI":"10.1001\/jamasurg.2022.4558"},{"issue":"6","key":"16971_CR37","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.3390\/jcm13061607","volume":"13","author":"AJ Dixon","year":"2024","unstructured":"Dixon AJ, Sladden M, Zouboulis CC, et al. Primary cutaneous melanoma-management in 2024. J Clin Med. 2024;13(6):1607. https:\/\/doi.org\/10.3390\/jcm13061607.","journal-title":"J Clin Med."},{"issue":"8","key":"16971_CR38","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/jso.21865","volume":"103","author":"WM Klop","year":"2011","unstructured":"Klop WM, Veenstra HJ, Vermeeren L, Nieweg OE, Balm AJ, Lohuis PJ. Assessment of lymphatic drainage patterns and implications for the extent of neck dissection in head and neck melanoma patients. J Surg Oncol. 2011;103(8):756\u201360. https:\/\/doi.org\/10.1002\/jso.21865.","journal-title":"J Surg Oncol."},{"issue":"17","key":"16971_CR39","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.1002\/cncr.25148","volume":"116","author":"R Murali","year":"2010","unstructured":"Murali R, Shaw HM, Lai K, et al. Prognostic factors in cutaneous desmoplastic melanoma: a study of 252 patients. Cancer. 2010;116(17):4130\u20138. https:\/\/doi.org\/10.1002\/cncr.25148.","journal-title":"Cancer."},{"issue":"4","key":"16971_CR40","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3390\/biomedicines8040070","volume":"8","author":"V Lavelli","year":"2020","unstructured":"Lavelli V, Ferrari C, Santo G, et al. The lymphoscintigraphic study of unpredictable head and neck cutaneous melanoma lymphatic drainage. Biomedicines. 2020;8(4):70. https:\/\/doi.org\/10.3390\/biomedicines8040070.","journal-title":"Biomedicines."},{"issue":"5","key":"16971_CR41","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1001\/jamaoto.2023.0076","volume":"149","author":"T Pasha","year":"2023","unstructured":"Pasha T, Arain Z, Buscombe J, et al. Association of complex lymphatic drainage in head and neck cutaneous melanoma with sentinel lymph node biopsy outcomes: a cohort study and literature review. JAMA Otolaryngol Head Neck Surg. 2023;149(5):416\u201323. https:\/\/doi.org\/10.1001\/jamaoto.2023.0076.","journal-title":"JAMA Otolaryngol Head Neck Surg."},{"issue":"32","key":"16971_CR42","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1200\/JCO.18.02306","volume":"37","author":"U Leiter","year":"2019","unstructured":"Leiter U, Stadler R, Mauch C, et al. Final analysis of DeCOG-SLT trial: no survival benefit for complete lymph node dissection in patients with melanoma with positive sentinel node. J Clin Oncol. 2019;37(32):3000\u20138. https:\/\/doi.org\/10.1200\/JCO.18.02306.","journal-title":"J Clin Oncol."},{"issue":"3","key":"16971_CR43","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.surg.2022.08.034","volume":"173","author":"MA Piltin","year":"2023","unstructured":"Piltin MA, Glasgow AE, Habermann EB, Hieken TJ. Intermediate-thickness melanoma: a population-based study of surgical quality metrics. Surgery. 2023;173(3):626\u201332. https:\/\/doi.org\/10.1016\/j.surg.2022.08.034.","journal-title":"Surgery."},{"issue":"4","key":"16971_CR44","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1245\/s10434-007-9789-6","volume":"15","author":"JL Erickson","year":"2008","unstructured":"Erickson JL, Velasco JM, Hieken TJ. Compliance with melanoma treatment guidelines in a community teaching hospital: time trends and other variables. Ann Surg Oncol. 2008;15(4):1211\u20137. https:\/\/doi.org\/10.1245\/s10434-007-9789-6.","journal-title":"Ann Surg Oncol."},{"issue":"7","key":"16971_CR45","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1245\/s10434-013-2883-z","volume":"20","author":"D Han","year":"2013","unstructured":"Han D, Zager JS, Yu D, et al. Desmoplastic melanoma: is there a role for sentinel lymph node biopsy? Ann Surg Oncol. 2013;20(7):2345\u201351. https:\/\/doi.org\/10.1245\/s10434-013-2883-z.","journal-title":"Ann Surg Oncol."},{"issue":"7","key":"16971_CR46","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.ejso.2013.02.025","volume":"39","author":"PN Broer","year":"2013","unstructured":"Broer PN, Walker ME, Goldberg C, et al. Desmoplastic melanoma: a 12-year experience with sentinel lymph node biopsy. Eur J Surg Oncol. 2013;39(7):681\u20135. https:\/\/doi.org\/10.1016\/j.ejso.2013.02.025.","journal-title":"Eur J Surg Oncol."},{"issue":"4","key":"16971_CR47","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1002\/cncr.21635","volume":"106","author":"TM Pawlik","year":"2006","unstructured":"Pawlik TM, Ross MI, Prieto VG, et al. Assessment of the role of sentinel lymph node biopsy for primary cutaneous desmoplastic melanoma. Cancer. 2006;106(4):900\u20136. https:\/\/doi.org\/10.1002\/cncr.21635.","journal-title":"Cancer."},{"issue":"12","key":"16971_CR48","doi-asserted-by":"publisher","first-page":"4441","DOI":"10.1016\/j.bjps.2022.08.044","volume":"75","author":"M Hodson","year":"2022","unstructured":"Hodson M, Feustel P, Davis L. Sentinel lymph node biopsy in desmoplastic melanoma: the percent desmoplastic component matters: a systematic review. J Plast Reconstr Aesthet Surg. 2022;75(12):4441\u20139. https:\/\/doi.org\/10.1016\/j.bjps.2022.08.044.","journal-title":"J Plast Reconstr Aesthet Surg."},{"issue":"1","key":"16971_CR49","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/ajd.12121","volume":"55","author":"MJ Lin","year":"2014","unstructured":"Lin MJ, Mar V, McLean C, Wolfe R, Kelly JW. Diagnostic accuracy of malignant melanoma according to subtype. Australas J Dermatol. 2014;55(1):35\u201342. https:\/\/doi.org\/10.1111\/ajd.12121.","journal-title":"Australas J Dermatol."},{"issue":"1","key":"16971_CR50","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1590\/abd1806-4841.20197481","volume":"94","author":"PC Marques","year":"2019","unstructured":"Marques PC, Diniz LM, Spelta K, Nogueira PSE. Desmoplastic melanoma: a rare variant with challenging diagnosis. An Bras Dermatol. 2019;94(1):82\u20135. https:\/\/doi.org\/10.1590\/abd1806-4841.20197481.","journal-title":"An Bras Dermatol."},{"key":"16971_CR51","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ehpc.2017.08.002","volume":"11","author":"K Yorita","year":"2018","unstructured":"Yorita K, Yoshii S, Kuroda N, et al. A case of desmoplastic melanoma that was difficult to distinguish from malignant peripheral nerve sheath tumor. Hum Pathol Case Rep. 2018;11:6\u201310. https:\/\/doi.org\/10.1016\/j.ehpc.2017.08.002.","journal-title":"Hum Pathol Case Rep"},{"issue":"4","key":"16971_CR52","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.jaad.2023.05.035","volume":"89","author":"A Rajeh","year":"2023","unstructured":"Rajeh A, Wan G, Roster K, et al. Underuse of sentinel lymph node biopsy for early-stage melanoma. J Am Acad Dermatol. 2023;89(4):803\u20136. https:\/\/doi.org\/10.1016\/j.jaad.2023.05.035.","journal-title":"J Am Acad Dermatol."},{"issue":"4","key":"16971_CR53","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/jso.26565","volume":"124","author":"J Narang","year":"2021","unstructured":"Narang J, Hue JJ, Bingmer K, et al. Sentinel lymph node biopsy guideline concordance in melanoma: analysis of the National Cancer Database. J Surg Oncol. 2021;124(4):669\u201378. https:\/\/doi.org\/10.1002\/jso.26565.","journal-title":"J Surg Oncol."},{"issue":"3","key":"16971_CR54","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1200\/JOP.2016.020156","volume":"13","author":"V Chollette","year":"2017","unstructured":"Chollette V, Beasley DD, Abdiwahab E, Taplin S. Health information systems approach to managing task interdependence in cancer care teams. J Oncol Pract. 2017;13(3):154\u20136. https:\/\/doi.org\/10.1200\/JOP.2016.020156.","journal-title":"J Oncol Pract."},{"issue":"2","key":"16971_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0247583","volume":"16","author":"O Asan","year":"2021","unstructured":"Asan O, Yu Z, Crotty BH. How clinician-patient communication affects trust in health information sources: temporal trends from a national cross-sectional survey. PLoS One. 2021;16(2):e0247583. https:\/\/doi.org\/10.1371\/journal.pone.0247583.","journal-title":"PLoS One."},{"key":"16971_CR56","unstructured":"American College of Surgeons Commission on Cancer. Optimal Resources for Cancer Care 2020 Standards. Available at: FACS.org."},{"issue":"3","key":"16971_CR57","first-page":"26","volume":"1","author":"TG Gutheil","year":"2004","unstructured":"Gutheil TG. Fundamentals of medical record documentation. Psychiatry (Edgmont). 2004;1(3):26\u20138.","journal-title":"Psychiatry (Edgmont)."},{"issue":"11","key":"16971_CR58","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1200\/JOP.2016.013573","volume":"12","author":"JR Trosman","year":"2016","unstructured":"Trosman JR, Carlos RC, Simon MA, et al. Care for a patient with cancer as a project: management of complex task interdependence in cancer care delivery. J Oncol Pract. 2016;12(11):1101\u201313. https:\/\/doi.org\/10.1200\/JOP.2016.013573.","journal-title":"J Oncol Pract."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-16971-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-16971-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-16971-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T12:57:58Z","timestamp":1748869078000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-16971-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":58,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["16971"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-16971-0","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]},"assertion":[{"value":"13 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Amelia Stapleton Van Doren, Hemali Shah, Ashar Ata, and Lindy Davis have no relevant conflicts of interest to declare that may be relevant to the contents of this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}